Eli Lilly Regains $1 Trillion Market Cap Amid GLP-1 Growth
LLY stock trades at 40 times trailing earnings as demand for weight-loss drugs drives valuation higher. Eli Lilly’s market capitalization has returned to $1 trillion, reflecting strong investor confidence in its GLP-1 weight-loss drugs, Mounjaro and Zepbound. The stock has